Agency Forms Undergoing Paperwork Reduction Act Review, 66531-66532 [E6-19260]
Download as PDF
66531
Federal Register / Vol. 71, No. 220 / Wednesday, November 15, 2006 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
State Health Departments ..............................
Adult Case Report: AIDS ...............................
Adult Case Report: HIV .................................
Peds Case Report: AIDS ...............................
Peds Case Report: HIV .................................
Case Report Updates ....................................
Incidence ........................................................
VARHS ...........................................................
EPS ................................................................
State Health Departments ..............................
State
State
State
State
Health
Health
Health
Health
Departments
Departments
Departments
Departments
..............................
..............................
..............................
..............................
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–19258 Filed 11–14–06; 8:45 am]
59
59
59
59
59
30
24
15
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
BILLING CODE 4163–18–P
The NBCCEDP was established in
response to the Congressional Breast
and Cervical Cancer Mortality
Prevention Act of 1990. This Act
mandates a program that will provide
early detection, breast and cervical
cancer screening services for underserved women.
CDC proposes to aggregate breast and
cervical cancer screening, diagnostic
and treatment data from NBCCEDP
grantees at the State, territory and tribal
level. These aggregated data will
include demographic information about
women served through funded
programs. The proposed data collection
will also include infrastructure data
about grantee management, public
education and outreach, professional
education, and service delivery.
Breast cancer is a leading cause of
cancer-related death among American
women. The American Cancer Society
(ACS) estimated that 211,240 new cases
would be diagnosed among women in
2005, and 40,410 women would die of
this disease. Mammography is
extremely valuable as an early detection
tool because it can detect breast cancer
well before the woman can feel the
lump, when it is still in an early and
more treatable stage. Women older than
age 40 that receive annual
mammography screening reduce their
probability of breast cancer mortality
and increase their treatment options.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–07–0571]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Minimum Data Elements (MDEs)/
System for Technical Assistance
Reporting (STAR) for the National
Breast and Cervical Cancer Early
Detection Program (NBCCEDP)—(OMB
Number 0920–0571)—Extension—
National Center for Chronic Disease
Average
number of
responses per
respondent
890
932
3
11
85
2,833
2,917
200
Average
burden per
response
(in hours)
⁄
⁄
⁄
20⁄60
5⁄60
10⁄60
5⁄60
25⁄60
20 60
20 60
20 60
Although early detection efforts have
greatly decreased the incidence of
invasive cervical cancer in recent
decades, ACS estimated that 10,370 new
cases would be diagnosed in 2005 and
3,710 women would die of this disease.
Papanicolaou (Pap) tests effectively
detect precancerous lesions in addition
to invasive cervical cancer. The
detection and treatment of precancerous
lesions can prevent nearly all cervical
cancer-related deaths.
Because breast and cervical cancer
screening, diagnostic and treatment data
are already collected and aggregated at
the State, territory and tribal level, the
additional burden on the grantees will
be small. Continuation of this program
will require grantees to report a
minimum data set (MDE) on screening
and follow-up activities electronically to
the CDC on a semi-annual basis. The
program will require grantees to report
infrastructure data (STAR) to the CDC
annually using a web-based system.
Information collected will be used to
obtain more complete breast and
cervical cancer data, promote public
education of cancer incidence and risk,
improve the availability of screening
and diagnostic services for under-served
women, ensure the quality of services
provided to women, and develop
outreach strategies for women that are
never or rarely screened for breast and
cervical cancer. Data collection will
continue for the next three years.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2,244.
Background and Brief Description
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents*
rmajette on PROD1PC67 with NOTICES1
Reports
*Infrastructure Report (STAR) .....................................................................................................
*Screening and Follow-up (MDE) ................................................................................................
Number of
responses per
respondent
68
68
* Respondents include State, territorial and tribal grantees.
VerDate Aug<31>2005
15:00 Nov 14, 2006
Jkt 211001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\15NON1.SGM
15NON1
1
2
Average
burden per
response
(in hours)
25
4
66532
Federal Register / Vol. 71, No. 220 / Wednesday, November 15, 2006 / Notices
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–19260 Filed 11–14–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-07–0469]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
National Program of Cancer
Registries—Cancer Surveillance
System—Extension (OMB number
0920–0469)-National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The American Cancer Society
estimated that about 1.37 million
Americans were newly diagnosed with
cancer in 2005 and that about 570,000
died from cancer in that same year. The
National Institutes of Health estimates
that in 2005, the cost of cancer was
about $209 billion, including $74 billion
direct costs to treat cancer, and $136
billion indirect costs in lost productivity
due to illness and premature death.
In 2002, CDC implemented the
National Program of Cancer Registries
(NPCR)—Cancer Surveillance System
(CSS) to collect, evaluate and
disseminate cancer incidence data
collected by population-based cancer
registries. In 2002, CDC began annually
publishing United States Cancer
Statistics (USCS). The latest USCS
report published in 2005 provided
cancer statistics for 93% of the United
States population from all cancer
registries whose data met national data
standards. Prior to the publication of
USCS, at the national level, cancer
incidence data were available for only
14% of the population of the United
States.
With this expanded coverage of the
U.S. population, it will now be possible
to better describe geographic variation
in cancer incidence throughout the
country and provide incidence data on
minority populations and rare cancers
to further plan and evaluate state and
national cancer control and prevention
efforts.
Therefore, CDC’s Division of Cancer
Prevention and Control proposes to
continue to aggregate existing cancer
incidence data from states funded by the
National Program of Cancer Registries
into a national surveillance system.
These data are already collected and
aggregated at the state level, thus, the
additional burden for the states is small.
Funded states are asked to continue to
report cancer incidence data to CDC on
an annual basis. Each state is requested
to report a cumulative file containing
incidence data from the first diagnosis
year for which the cancer registry
collected data with the assistance of
NPCR funds (e.g., 1995) through 12
months past the close of the most recent
diagnosis year (e.g., 2004).
NCCDPHP is requesting a 3 year
clearance for this project. The total
number of eligible respondents is 63
which includes 50 States, 12 territories,
and the District of Columbia. The total
estimated annualized burden hours are
126 (i.e., 2 hours per respondent). There
are no costs to the respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
Number of
respondents
Number of
responses
per respondent
Average
burden
per response
(in hours)
States, Territories, and the District of Columbia (Cancer Registries) .........................................
63
1
2
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–19261 Filed 11–14–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
rmajette on PROD1PC67 with NOTICES1
[60Day–07–06BV]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
VerDate Aug<31>2005
17:21 Nov 14, 2006
Jkt 211001
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Travel-Related Infectious Diseases
Risk Perception, Prevention Measures,
and Behaviors during Travel to Latin
America Visiting Friends and Relatives
(VFR) versus non-VFR Travelers—
New—National Center for Infectious
E:\FR\FM\15NON1.SGM
15NON1
Agencies
[Federal Register Volume 71, Number 220 (Wednesday, November 15, 2006)]
[Notices]
[Pages 66531-66532]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-19260]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-07-0571]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
Minimum Data Elements (MDEs)/System for Technical Assistance
Reporting (STAR) for the National Breast and Cervical Cancer Early
Detection Program (NBCCEDP)--(OMB Number 0920-0571)--Extension--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The NBCCEDP was established in response to the Congressional Breast
and Cervical Cancer Mortality Prevention Act of 1990. This Act mandates
a program that will provide early detection, breast and cervical cancer
screening services for under-served women.
CDC proposes to aggregate breast and cervical cancer screening,
diagnostic and treatment data from NBCCEDP grantees at the State,
territory and tribal level. These aggregated data will include
demographic information about women served through funded programs. The
proposed data collection will also include infrastructure data about
grantee management, public education and outreach, professional
education, and service delivery.
Breast cancer is a leading cause of cancer-related death among
American women. The American Cancer Society (ACS) estimated that
211,240 new cases would be diagnosed among women in 2005, and 40,410
women would die of this disease. Mammography is extremely valuable as
an early detection tool because it can detect breast cancer well before
the woman can feel the lump, when it is still in an early and more
treatable stage. Women older than age 40 that receive annual
mammography screening reduce their probability of breast cancer
mortality and increase their treatment options.
Although early detection efforts have greatly decreased the
incidence of invasive cervical cancer in recent decades, ACS estimated
that 10,370 new cases would be diagnosed in 2005 and 3,710 women would
die of this disease. Papanicolaou (Pap) tests effectively detect
precancerous lesions in addition to invasive cervical cancer. The
detection and treatment of precancerous lesions can prevent nearly all
cervical cancer-related deaths.
Because breast and cervical cancer screening, diagnostic and
treatment data are already collected and aggregated at the State,
territory and tribal level, the additional burden on the grantees will
be small. Continuation of this program will require grantees to report
a minimum data set (MDE) on screening and follow-up activities
electronically to the CDC on a semi-annual basis. The program will
require grantees to report infrastructure data (STAR) to the CDC
annually using a web-based system. Information collected will be used
to obtain more complete breast and cervical cancer data, promote public
education of cancer incidence and risk, improve the availability of
screening and diagnostic services for under-served women, ensure the
quality of services provided to women, and develop outreach strategies
for women that are never or rarely screened for breast and cervical
cancer. Data collection will continue for the next three years.
There are no costs to respondents other than their time. The total
estimated annualized burden hours are 2,244.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Reports respondents* responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
*Infrastructure Report (STAR)................................... 68 1 25
*Screening and Follow-up (MDE).................................. 68 2 4
----------------------------------------------------------------------------------------------------------------
* Respondents include State, territorial and tribal grantees.
[[Page 66532]]
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-19260 Filed 11-14-06; 8:45 am]
BILLING CODE 4163-18-P